Welcome to Novo Nordisk in the United States


Novo Nordisk in the U.S.

 

Novo Nordisk discovers and develops innovative medicines and makes them accessible to patients throughout the world. Nearly a century of innovation and leadership has led to the development of a comprehensive portfolio of products and delivery systems for diabetes care, as well as in other therapeutic areas where the company can make a difference. Novo Nordisk, Inc., is the US affiliate of Novo Nordisk A/S. We are one of the world’s leading diabetes care company. The company’s US headquarters are located in Plainsboro, NJ, and the Novo Nordisk US business presence stretches from coast to coast -- from an insulin manufacturing plant in North Carolina to the Novo Nordisk Research Center in Seattle, WA.

Access each of our location pages below to read more about our sites within the U.S. and learn more about our company’s History.

 


Plainsboro, NJ

Our United States headquarters, in Plainsboro, New Jersey, plays a critical role in the vibrancy of the life sciences industry in New Jersey.

Learn more

Clayton, NC

DFP helps support Novo Nordisk as a leader in diabetes by providing a complete product portfolio of insulin and GLP-1 products.

DAPI will support Novo Nordisk in production and engineering.

Learn more

Seattle, WA

Established in 2009, the Novo Nordisk Research Center Seattle, Inc. (NNRCSI) is focused on early discovery projects within the diabetes and obesity areas.

Learn more

 

West Lebanon, NH

Located in West Lebanon, New Hampshire, Novo Nordisk US Bio Production, Inc. (NNUSBPI), is a biopharmaceutical manufacturing facility.

Learn more

Indianapolis, IN

NNRCII (Novo Nordisk Research Center Indianapolis, Inc.) is focused on early discovery projects within the diabetes and obesity areas.

Learn more